Is a complete BCBA/TEMD research report available?

No complete published report is available for bcba/TEMD (BCBA/TEMD) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BCBA/TEMD (BCBA/TEMD)

Buenos Aires Stock Exchange: BCBA/TEMD · USD

$3.83

+0.23 (+6.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BCBA/TEMD analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	11.2T
Revenue (ttm)	1.9T
Net income (ttm)	-418.5B
EPS (ttm)	-$2,381
Volume	401

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.9T
Net income (ttm): -418.5B
EPS (ttm): -$2,381
Market cap: 11.2T

All BCBA/TEMD indicators

Market & fundamental data

Available fields

151

Groups with data

Currency

USD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	3,800
Employees Change	1,400%
Employees Change Percent	58.33
Enterprise value	$12.2T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-07-12
Industry	Medical Laboratories
Last refreshed	2026-07-31
Market cap	$11.2T
Price	$3.83
Price currency	USD
Rev Per Employee	495,951,784.5x
Sic	8071
Symbol	bcba/TEMD
Website	https://www.tempus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.74%
EV/Sales	5.98x
FCF yield	-2.63%
P/B ratio	19.46x
P/S ratio	5.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-19.56%
EBITDA Margin	-13.58%
Gross margin	63.39%
Gross Profit	$1.2T
Gross Profit Growth	88.55%
Gross Profit Growth Q	43.06%
Gross Profit Growth3 Y	94.17%
Net Income	$-418.5B
Pretax Margin	-22.61%
Profit Margin	-22.2%
Profit Per Employee	$-110.1M
ROA	-9.07
Roa5y	-27.91
ROCE	-14.68
ROE	-81.58
ROIC	-11.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	69.82x
Revenue Growth Q	36.12x
Revenue Growth3 Y	66.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.74
Assets	$2.9T
Cash	$882.9B
Current Assets	$1.6T
Current Liabilities	$473.4B
Debt	$1.8T
Debt Equity	$3.17
Debt FCF	$-6.19
Equity	$575.3B
Interest Coverage	-4.01
Liabilities	$2.4T
Long Term Assets	$1.4T
Long Term Liabilities	$1.9T
Net Cash	$-938.7B
Net Cash By Market Cap	$-8.39
Net Debt Equity	$1.63
Tangible Book Value	$-544.1B
Tangible Book Value Per Share	$-3,036

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.31
Inventory Turnover	9.76
Net Working Capital	$151.3B
Quick ratio	2.99
Working Capital	$1T
Working Capital Turnover	$3,872

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	4.37
All Time High	6.04
All Time High Change	-38.19%
All Time High Date	2025-08-14
All Time Low	3.6
All Time Low Change	6.4%
All Time Low Date	2026-07-30
ATR	0.22
Ch YTD	-38.19
High	3.83
High52	6.04
High52 Date	2025-08-14
High52ch	-36.62%
Low	3.6
Low52	3.6
Low52 Date	2026-07-29
Low52ch	6.25%
Ma50ch	-14.68%
RSI	35.96
RSI Monthly	0
RSI Weekly	39.62
Sharpe ratio	-1.47x
Sortino ratio	-2.05
Total Return	-20.28%
Tr YTD	-38.19
Tr1m	-28.13%
Tr1w	-8.58%
Tr3m	-20.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-368.6B
Operating margin	-19.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	114,768,946%
Net Borrowing	657,780,632,186
Shares Insiders	35.38%
Shares Institutions	52.6%
Shares Qo Q	0.46%
Shares Yo Y	20.28%
Short Ratio	4.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-507.6B
Adjusted OCF	-470,021,354,041
Average Volume	754.45x
Bv Per Share	3,209.8
CAPEX	$-37.5B
Ch1m	-28.13
Ch1w	-8.58
Ch3m	-20.21
Ch6m	-31.43
Change	6.25%
Change From Open	2.55
Close	3.6
Days Gap	3.61
Depreciation Amortization	121,473,007,656.5
Dollar Volume	1,533.8
Earnings Date	2026-07-30
EBIT	$-368.6B
EBITDA	$-255.9B
EPS	$-2,381
F Score	3
FCF	$-294.2B
FCF EV Yield	-2.41x
Financing CF	816,212,109,097
Fiscal Year End	December
Founded	2,015
Goodwill	700,075,293,718.5
Income Tax	$-7.7B
Investing CF	-45,042,872,675
Is Primary Listing	0
Last Earnings Date	2026-07-30
Last Report Date	2026-03-31
Ma20	4.63
Ma20ch	-19.44%
Net CF	514,666,350,771
Next Earnings Date	2026-07-30
Open	3.73
Position In Range	100
Ppne	224,686,573,863.5
Price Date	2026-07-30
Relative Volume	0.44x
Revenue	1,884,616,781,102x
SBC By Revenue	11.32x
Share Based Comp	213,414,854,862
Tax By Revenue	-0.41x
Tr6m	-31.43%
Volume	401
Z Score	3.01

BCBA/TEMD (BCBA/TEMD)

Coverage state: Market snapshot only — no published research

Generate the first BCBA/TEMD analysis

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/TEMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/TEMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BCBA/TEMD

Frequently asked questions